Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
OPKO Health Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
OPK
Nasdaq
2834
https://www.opko.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for OPKO Health Inc
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
- May 9th, 2024 1:18 pm
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
- May 8th, 2024 3:47 pm
Q1 2024 OPKO Health Inc Earnings Call
- May 8th, 2024 10:56 am
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
- May 8th, 2024 7:44 am
Opko Health (OPK) Q1 2024 Earnings Call Transcript
- May 8th, 2024 1:15 am
OPKO Health (OPK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- May 8th, 2024 12:30 am
OPKO Health Inc (OPK) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
- May 7th, 2024 10:09 pm
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
- May 7th, 2024 9:30 pm
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
- May 7th, 2024 8:05 pm
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
- May 3rd, 2024 12:00 pm
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
- Apr 1st, 2024 5:01 pm
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
- Apr 1st, 2024 4:42 pm
Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets
- Mar 29th, 2024 3:08 am
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
- Mar 28th, 2024 12:00 pm
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
- Mar 25th, 2024 1:57 pm
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
- Mar 20th, 2024 12:00 pm
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
- Mar 5th, 2024 1:52 pm
Analysts Have Lowered Expectations For OPKO Health, Inc. (NASDAQ:OPK) After Its Latest Results
- Mar 1st, 2024 10:51 am
OPKO Health, Inc. (NASDAQ:OPK) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 1:31 pm
OPKO Health Full Year 2023 Earnings: EPS Beats Expectations
- Feb 29th, 2024 10:50 am
Scroll